Anthropic Claude Science launches as an AI-powered research workspace, helping scientists analyze data, manage workflows, and accelerate discoveries.
Anthropic Claude Science is making its debut as a new AI-powered research platform designed to help scientists manage complex studies from one place. Instead of moving between multiple databases, software tools, and computing systems, researchers can now work within a single environment that combines literature analysis, data processing, visualization, and manuscript preparation.
A Step Toward Simpler Scientific Research
Anthropic says Claude Science is not a new AI model. It runs on the company's existing Claude models and is available in beta for Pro, Max, Team, and Enterprise subscribers. The goal is to simplify research workflows and help scientists spend more time on discovery rather than administrative tasks.
The platform comes connected to more than 60 scientific databases and includes specialized tools for genomics, protein structure analysis, chemistry, and biomedical research. Researchers can analyze scientific papers, run calculations, generate figures, and track every result back to its original source code and computing environment. Claude Science can also display scientific content such as 3D protein structures, genome browser tracks, and chemistry diagrams, making it easier for researchers to interpret complex data.
What Makes Claude Science Different?
Rather than creating a specialized biology model, Anthropic has focused on building a complete research workspace. The system can create AI sub-assistants that handle different parts of a project, acting like a team of digital research helpers. It also includes a verification system that checks citations and calculations before findings are prepared for publication.
Another important feature is flexibility. Organizations can run Claude Science on their own infrastructure, allowing sensitive research data to remain on-site instead of being sent to external servers.
Can AI Help Discover New Medicines Faster?
Alongside the launch, the company announced plans to begin its own pre-clinical drug discovery programs focused on neglected diseases. These are illnesses that often receive limited investment from traditional pharmaceutical companies despite affecting millions of people worldwide.
According to Anthropic's life sciences leader Eric Kauderer-Abrams, the company wants hands-on experience in drug development to better understand the challenges researchers face and build more useful AI tools. The move follows Anthropic's growing presence in life sciences through partnerships with healthcare organizations, vaccine research initiatives, and the acquisition of AI biotech startup Coefficient Bio.
Growing Competition in Scientific AI
The launch arrives as competition in AI-driven science continues to intensify. OpenAI recently introduced GPT-Rosalind, a biology-focused reasoning model, while Google DeepMind is expanding its Gemini for Science platform using tools such as AlphaFold and AlphaGenome.
Each company is taking a different path. Anthropic is focusing on accessible research workflows, OpenAI is targeting enterprise scientific users, and Google is building around its proprietary scientific models.
Anthropic has also launched a research support program that will fund up to 50 Claude Science projects with credits worth as much as $30,000 per project. Applications are open until July 15, 2026, with an initial focus on graduate students and postdoctoral researchers in biomedical sciences.
Looking Ahead
As Business Fortune observes, AI becomes more deeply integrated into scientific research and platforms like Claude Science could help shorten research timelines, improve collaboration, and accelerate discoveries. With Anthropic now entering both research software and drug development, the company is positioning itself as a major player in the future of life sciences, where AI may increasingly assist scientists from early discovery to real-world medical breakthroughs.
FAQs
What is Claude Science?
Claude Science is Anthropic's AI-powered research workbench that combines scientific databases, computing tools, research workflows, and AI assistance into one platform.
Is Claude Science a new AI model?
No. Claude Science uses Anthropic's existing Claude models and is not a separate biology-specific AI model.
How many scientific databases does Claude Science connect to?
The platform comes pre-configured with access to more than 60 scientific databases.
Who can access Claude Science?
The beta version is available to Anthropic's Pro, Max, Team, and Enterprise subscribers.
What diseases will Anthropic's drug discovery program focus on?
The company plans to focus initially on neglected diseases that often receive less attention and investment from traditional pharmaceutical and biotech companies.
